PATENT CLAIM ANALYSIS

Application Number: 16295536
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-08
Patent Classification: ["424", "133100"]

Abstract:
Biomarkers predictive of responsiveness to integrin beta7 antagonists, including anti-beta7 integrin subunit antibodies, and methods of using such biomarkers are provided. In addition, methods of treating gastrointestinal inflammatory disorders such as inflammatory bowel diseases including ulcerative colitis and Crohn's disease are provided. Also provided are methods of using such predictive biomarkers for the treatment of inflammatory bowel diseases including ulcerative colitis and Crohn's disease.

Claim (Index 4):
The method of  claim 1 , wherein the gastrointestinal inflammatory disorder is an inflammatory bowel disease.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 99.0
- Lexical Diversity: 1.84615
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15271687', '14675081', '13348709', '12390730', '11219121']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7057068907113601
- 35 USC 102 Novelty (BERT): 0.7850819034515554
- Combined Prediction Score: 0.7136443919853797
- Mean Citation Score: 470.705118
- Max Citation Score: 938.87976
- Similarity Product: 931.2063621125652

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test